Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine
Clinical and Experimental Dermatology · 2023
DOI: 10.1093/ced/llac045 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical and Experimental Dermatology, 2023. Verfasst von Dillon Mintoff und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Mater Dei Hospital, Malta. Hauptthemen laut MEDLINE: Hidradenitis Suppurativa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben.
Abstract (Originalsprache)
Hidradenitis suppurativa (HS) is a chronic inflammatory condition of the pilosebaceous unit characterized by inflammation and hyperkeratinization. A small but significant proportion of patients with HS have a strong genetic susceptibility to (or a syndromic form of) the disease. Current HS treatment guidelines prioritize patients who manifest classic HS and may therefore not be suitable for the minority of patients harbouring genetically driven forms of disease. In this manuscript, we review the extant literature with regards to therapeutic strategies used for patients with HS having disease-associated genetic variants and syndromic forms of the condition. The findings of this review suggest that patients with HS harbouring underlying genetic variants may not be adequately represented in current European and British HS treatment guidelines. Moreover, these patients may be less responsive to the recommended therapeutic options. We therefore make recommendations for future therapeutic guidelines to incorporate considerations for the management of this patient subset.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Dermatology, Mater Dei Hospital, Malta.
- Department of Pathology, Faculty of Medicine and Surgery, University of Malta, Malta.
- Department of Anatomy, Faculty of Medicine and Surgery, University of Malta, Malta.
- Centre for Molecular Medicine and Biobanking, University of Malta, Malta.
- Department of Pathology, Mater Dei Hospital, Malta.
ORCID-Profile: Dillon Mintoff, Nikolai P Pace, Isabella Borg
Zitieren
APA
Mintoff, D., Pace, N. P., & Borg, I. (2023). Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llac045
Vancouver
Mintoff D, Pace NP, Borg I. Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine. Clinical and Experimental Dermatology. 2023. doi:10.1093/ced/llac045
BibTeX
@article{Mintoff2023,
author = {Mintoff, Dillon and Pace, Nikolai P and Borg, Isabella},
title = {Management of patients with hidradenitis suppurativa having underlying genetic variation: a systematic review and a call for precision medicine},
journal = {Clinical and Experimental Dermatology},
year = {2023},
doi = {10.1093/ced/llac045}
}
EUVIMED